{"entity":{"type":"insider","cik":"0001664708","url":"/insider/0001664708","json_url":"/insider/0001664708.json","name":"Mohindru Mani","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2018-10-19","last":"2026-07-16","span_basis":"filed_date"},"name_variants":[{"name":"Mohindru Mani","source":"filing","n_filings":9,"first_seen":"2018-10-19","last_seen":"2026-07-16"}],"transactions":[{"id":5798400,"accession":"0001193125-26-306072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-306072","line_url":"/filing/0001193125-26-306072#line-1","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"Cardiff Oncology, Inc.","issuer_ticker":"CRDF","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001664708","owner_name":"Mohindru Mani","owner_url":"/insider/0001664708","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34364.0,"shares_display":"34,364","price_per_share":1.455,"price_display":"1.46","price_state":"stated","total_value":49999.62,"total_display":"49,999.62","shares_owned_after":59067.0,"shares_owned_after_display":"59,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-14","filed_date":"2026-07-16","scope":"insider"},{"id":5840170,"accession":"0001664708-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001664708-26-000002","line_url":"/filing/0001664708-26-000002#line-1","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"Cardiff Oncology, Inc.","issuer_ticker":"CRDF","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001664708","owner_name":"Mohindru Mani","owner_url":"/insider/0001664708","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24703.0,"shares_display":"24,703","price_per_share":1.21,"price_display":"1.21","price_state":"stated","total_value":29890.63,"total_display":"29,890.63","shares_owned_after":24703.0,"shares_owned_after_display":"24,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-18","filed_date":"2026-06-22","scope":"insider"},{"id":8494250,"accession":"0001209191-19-059183","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-059183","line_url":"/filing/0001209191-19-059183#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001664708","owner_name":"Mohindru Mani","owner_url":"/insider/0001664708","role":"Officer (CFO & Chief Strategy Officer)","officer_title":"CFO & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4755.0,"shares_display":"4,755","price_per_share":17.05,"price_display":"17.05","price_state":"stated","total_value":81072.75,"total_display":"81,072.75","shares_owned_after":17441.0,"shares_owned_after_display":"17,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-04","filed_date":"2019-12-04","scope":"insider"},{"id":8727876,"accession":"0001209191-19-042480","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-042480","line_url":"/filing/0001209191-19-042480#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001664708","owner_name":"Mohindru Mani","owner_url":"/insider/0001664708","role":"Officer (CFO & Chief Strategy Officer)","officer_title":"CFO & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37431.0,"shares_display":"37,431","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":935775.0,"total_display":"935,775.00","shares_owned_after":13863.0,"shares_owned_after_display":"13,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-15","filed_date":"2019-07-17","scope":"insider"},{"id":8618528,"accession":"0001209191-19-033517","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-033517","line_url":"/filing/0001209191-19-033517#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001664708","owner_name":"Mohindru Mani","owner_url":"/insider/0001664708","role":"Officer (CFO & Chief Strategy Officer)","officer_title":"CFO & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2496.0,"shares_display":"2,496","price_per_share":21.39,"price_display":"21.39","price_state":"stated","total_value":53389.44,"total_display":"53,389.44","shares_owned_after":13863.0,"shares_owned_after_display":"13,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-29","filed_date":"2019-05-30","scope":"insider"},{"id":8296249,"accession":"0001209191-19-019712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-019712","line_url":"/filing/0001209191-19-019712#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001664708","owner_name":"Mohindru Mani","owner_url":"/insider/0001664708","role":"Officer (CFO & Chief Strategy Officer)","officer_title":"CFO & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16041.0,"shares_display":"16,041","price_per_share":19.12,"price_display":"19.12","price_state":"stated","total_value":306703.92,"total_display":"306,703.92","shares_owned_after":8026.0,"shares_owned_after_display":"8,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-13","filed_date":"2019-03-15","scope":"insider"},{"id":8525671,"accession":"0001209191-19-000403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-000403","line_url":"/filing/0001209191-19-000403#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001664708","owner_name":"Mohindru Mani","owner_url":"/insider/0001664708","role":"Officer (CFO & Chief Strategy Officer)","officer_title":"CFO & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":12.55,"price_display":"12.55","price_state":"stated","total_value":56475.0,"total_display":"56,475.00","shares_owned_after":8026.0,"shares_owned_after_display":"8,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-28","filed_date":"2019-01-02","scope":"insider"},{"id":6202675,"accession":"0001209191-18-058944","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-058944","line_url":"/filing/0001209191-18-058944#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001664708","owner_name":"Mohindru Mani","owner_url":"/insider/0001664708","role":"Officer (CFO & Chief Strategy Officer)","officer_title":"CFO & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16042.0,"shares_display":"16,042","price_per_share":18.5,"price_display":"18.50","price_state":"stated","total_value":296777.0,"total_display":"296,777.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2018-11-16","scope":"insider"},{"id":6426750,"accession":"0001209191-18-055685","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-055685","line_url":"/filing/0001209191-18-055685#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001664708","owner_name":"Mohindru Mani","owner_url":"/insider/0001664708","role":"Officer (CFO & Chief Strategy Officer)","officer_title":"CFO & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16042.0,"shares_display":"16,042","price_per_share":20.19,"price_display":"20.19","price_state":"stated","total_value":323887.98,"total_display":"323,887.98","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-17","filed_date":"2018-10-19","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001213037","name":"Cardiff Oncology, Inc.","url":"/issuer/0001213037","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2026-06-22","last_seen":"2026-07-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001346830","name":"Cara Therapeutics, Inc.","url":"/issuer/0001346830","role":"Officer (CFO & Chief Strategy Officer)","n_filings":7,"first_seen":"2018-10-19","last_seen":"2019-12-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001664708","retrieved_at":"2026-08-22T01:41:10+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}